AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Supraglip-M Tablet SR

Prescription Icon
Prescription Required

Marketer

Oaknet Healthcare Pvt Ltd

Salt Composition

Metformin (500mg) + Teneligliptin (20mg)

Overview Supraglip-M Tablet SR

Combiflex-D extended-release tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent severe diabetic complications like nephropathy and vision loss, potentially lowering the risk of cardiovascular events like stroke or myocardial infarction. Combiflex-D may be prescribed independently or in conjunction with other antidiabetic agents. Optimal efficacy is achieved when combined with a balanced diet and regular physical activity. Dosage is personalized based on your medical history, blood glucose readings, and other medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under physician guidance. Effective blood sugar control helps avert future complications. Adherence to your doctor's dietary and exercise regimen is crucial for optimal diabetes management; lifestyle significantly impacts disease control. Common side effects include nausea, vomiting, diarrhea, abdominal distress, and cephalalgia. Hypoglycemia is a potential adverse event, particularly when used with insulin or sulfonylureas; understanding its signs and management is vital. This medication isn't suitable for all patients. Prior to commencing treatment, inform your physician of any history of hepatic, renal, or cardiac disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before use. Drug interactions are possible; disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your physician will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of Supraglip-M Tablet SR

There is no text provided to rewrite.

Uses of Supraglip-M Tablet SR

Managing type 2 diabetes

Major Benefits of Supraglip-M Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Supraglip-M Tablet SR with a meal.

Common Side effects of Supraglip-M Tablet SR:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Supraglip-M Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Supraglip-M Tablet SR with a meal.

How Supraglip-M Tablet SR works:

Metformin and glimepiride extended-release tablets comprise Supraglip-M SR's dual-action antidiabetic formula.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Supraglip-M Tablet SR and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Supraglip-M Tablet SR during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Supraglip-M tablets may pose a risk to breastfeeding infants. Available human data indicate potential transfer to breast milk, possibly causing harm to the nursing child.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Supraglip-M Tablet SR on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Patients with kidney impairment should use Supraglip-M Tablet SR cautiously, potentially requiring dose modification. Consult your physician for guidance. Supraglip-M Tablet SR is contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver impairment should likely refrain from using Supraglip-M Tablet SR due to potential safety concerns. A physician's consultation is advised.

What if you forget to take Supraglip-M Tablet SR :

Should you forget a Supraglip-M Tablet SR dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Supraglip-M Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Supraglip-M Tablet SR

Supraglip-M Tablet SR is safe when used as directed by your doctor. However, even with proper use, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar) may occur. Hypoglycemia is more likely if you're also taking insulin or sulfonylurea. Report any persistent issues to your doctor.
Supraglip-M SR tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from insufficient caloric intake while using this medication. Symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may occur, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Supraglip-M Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Always seek medical advice before taking any other medication.
Supraglip-M Tablet SR is contraindicated in patients with allergies to its components or excipients. It should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Supraglip-M Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a rare but serious side effect due to excessive blood lactic acid. It's avoided in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Supraglip-M Tablet SR and seek immediate medical attention.
Prolonged use of Supraglip-M Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may result in anemia, nerve damage (potentially causing tingling, numbness in extremities, weakness, and urinary issues), cognitive changes, and balance problems (ataxia). If you experience any of these symptoms, consult your physician for potential vitamin B12 level monitoring and supplementation.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Supraglip-M Tablet SR
148
MRP 171
13% off